ArticleCancer medicine2020

MicroRNA-221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling.

Yingchun Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.